HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Onlay tibial implants appear to provide superior clinical results in robotic unicompartmental knee arthroplasty.

AbstractBACKGROUND:
Unicompartmental knee arthroplasty (UKA) is an increasingly popular option for the treatment of single-compartment knee osteoarthritis (OA) in adults. Two options for tibial resurfacing during UKA are (1) all-polyethylene inlays and (2) metal-backed onlays.
QUESTIONS/PURPOSES:
The aim of this study was to determine whether there are any differences in clinical outcomes with inlay versus onlay tibial components.
PATIENTS AND METHODS:
We identified 39 inlays and 45 onlays, with average 2.7- and 2.3-year follow-up, respectively, from a prospective robotic-assisted surgery database. The primary outcome was the Western Ontario and McMaster University Arthritis Index (WOMAC), subcategorized by the pain, stiffness, and function subscores, at 2 years postoperatively. The secondary outcome was the need for secondary or revision surgery.
RESULTS:
Postoperative WOMAC pain score was 3.1 for inlays and 1.6 for onlays (p = 0.03). For 25 inlays and 30 onlays with both preoperative and postoperative WOMAC data, pain score improved from 8.3 to 4.0 for inlays versus from 9.2 to 1.7 for onlays (p = 0.01). Function score improved from 27.5 to 12.5 for inlays versus from 32.1 to 7.3 for onlays (p = 0.03). Four inlays and one onlay required a secondary or revision procedure (p = 0.18).
CONCLUSIONS:
We advise using metal-backed onlays during UKA to improve postoperative clinical outcomes.
AuthorsBrian P Gladnick, Denis Nam, Saker Khamaisy, Sophia Paul, Andrew D Pearle
JournalHSS journal : the musculoskeletal journal of Hospital for Special Surgery (HSS J) Vol. 11 Issue 1 Pg. 43-9 (Feb 2015) ISSN: 1556-3316 [Print] United States
PMID25737668 (Publication Type: Journal Article)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: